Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease

被引：6941

作者：

Hansson, GK ^{[1
]}

机构：

[1] Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, Dept Med, SE-17176 Stockholm, Sweden

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 352卷 / 16期

关键词：

D O I：

10.1056/NEJMra043430

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In this review article, Göran Hansson, a pioneer in the study of the role of inflammation in atherosclerosis and coronary artery disease, summarizes new ideas on the pathogenesis of acute coronary syndromes.

引用

页码：1685 / 1695

页数：11

共 114 条

[71] A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation [J].

Massberg, S ;

Brand, K ;

Grüner, S ;

Page, S ;

Müller, E ;

Müller, I ;

Bergmeier, W ;

Richter, T ;

Lorenz, M ;

Konrad, I ;

Nieswandt, B ;

Gawaz, M .

JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (07) :887-896

[72] Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial [J].

McCarey, DW ;

McInnes, LB ;

Madhok, R ;

Hampson, R ;

Scherbakova, O ;

Ford, I ;

Capell, HA ;

Sattar, N .

LANCET, 2004, 363 (9426) :2015-2021

[73] Oxidized low density lipoprotein and innate immune receptors [J].

Miller, YI ;

Chang, MK ;

Binder, CJ ;

Shaw, PX ;

Witztum, JL .

CURRENT OPINION IN LIPIDOLOGY, 2003, 14 (05) :437-445

[74] MACROPHAGE INFILTRATION IN ACUTE CORONARY SYNDROMES - IMPLICATIONS FOR PLAQUE RUPTURE [J].

MORENO, PR ;

FALK, E ;

PALACIOS, IF ;

NEWELL, JB ;

FUSTER, V ;

FALLON, JT .

CIRCULATION, 1994, 90 (02) :775-778

[75] Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study [J].

Murray, CJL ;

Lopez, AD .

LANCET, 1997, 349 (9063) :1436-1442

[76] Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse [J].

Nakashima, Y ;

Raines, EW ;

Plump, AS ;

Breslow, JL ;

Ross, R .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (05) :842-851

[77] Immunomodulation of atherosclerosis - Implications for vaccine development [J].

Nilsson, J ;

Hansson, GK ;

Shah, PK .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (01) :18-28

[78] Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease [J].

Nissen, SE ;

Tuzcu, EM ;

Schoenhagen, P ;

Crowe, T ;

Sasiela, WJ ;

Tsai, J ;

Orazem, J ;

Magorien, RD ;

O'Shaughnessy, C ;

Ganz, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (01) :29-38

[79] Azithromycin for the secondary prevention of coronary heart disease events - The WIZARD study: A randomized controlled trial [J].

O'Connor, CM ;

Dunne, MW ;

Pfeffer, MA ;

Muhlestein, JB ;

Yao, L ;

Gupta, S ;

Benner, RJ ;

Fisher, MR ;

Cook, TD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (11) :1459-1466

[80] IMMUNIZATION OF LOW-DENSITY-LIPOPROTEIN (LDL) RECEPTOR-DEFICIENT RABBITS WITH HOMOLOGOUS MALONDIALDEHYDE-MODIFIED LDL REDUCES ATHEROGENESIS [J].

PALINSKI, W ;

MILLER, E ;

WITZTUM, JL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (03) :821-825

← 3 4 5 6 7 8 9 10 11 12 →